. Author manuscript; available in PMC: 2015 Sep 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Jun 11;23(9):1804–1812. doi: 10.1158/1055-9965.EPI-14-0029

Table 4.

Summary of diagnostic sensitivity of 10-biomarker panel and voided urinary cytology in bladder cancer patients

	Number of BCa cases predicted by biomarker panel	Sensitivity (%)	Number of BCa cases predicted by voided urinary cytology	Sensitivity (%)
Overall	151 of 183	82.5	56 of 79	70.9
Low-grade tumors	69 of 77	89.6	12 of 29	41.4
High-grade tumors	79 of 98	80.6	44 of 50	88.0
NMIBC	118 of 153	77.1	50 of 73	68.5
MIBC	21 of 22	95.5	6 of 6	100

NMIBC, non-muscle invasive bladder cancer

MIBC, muscle invasive bladder cancer